|
|
Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients
|
|
|
|
|
نویسنده
|
Wang Hong-Bo ,Yuan Li ,Lin Zhi-Rui ,Xia Tian-Liang ,Li Man-Zhi ,Liu Yan-Min ,Huang Xiao-Ming ,Zhang Hua ,Zhong Qian ,He Jiang-Yi ,Han Ping ,Zhang Yu ,Liu Yong-Dong ,Song Shi-Jian ,Feng Guo-Kai ,An Yu ,Zhou Ai-Jun
|
منبع
|
journal of molecular medicine - 2018 - دوره : 96 - شماره : 3-4 - صفحه:265 -279
|
چکیده
|
Lymph node metastasis (n classification) is one of the most important prognostic factors of nasopharyngeal carcinoma (npc), and nerve involvement is associated with the transition of the n category in npc patients. although the nervous system has been reported to participate in many types of cancer progression, its functions in npc progression remains unknown. through analysis of gene profiling data, we demonstrate an enrichment of genes associated with neuronal development and differentiation in npc tissues and cell lines. among these genes, nogo receptor 3 (ngr3), which was originally identified in the nervous system and plays a role in nerve development and regeneration, was inappropriately overexpressed in npc cells and tissues. immunohistochemical analysis demonstrated that the overexpression of ngr3 was correlated with poor prognosis in npc patients. overexpression of ngr3 promoted, and knocking down ngr3 inhibited, npc cell migration and invasion in vitro and metastasis in vivo. the ability of ngr3 to promote cell migration was triggered by the downregulation of e-cadherin and enhanced cytoskeletal rearrangement and cell polarity, which were correlated with the activation of focal adhesion kinase (fak). collectively, ngr3 is a novel indicator of poor outcomes in npc patients and plays an important role in driving the progression of npc. these results suggest a potential link between the nervous system and npc progression.
|
کلیدواژه
|
NgR3 ,Nasopharyngeal carcinoma ,Metastasis ,E-cadherin
|
آدرس
|
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China, Sun Yat-sen University, Department of Otolaryngology-Head and Neck Surgery, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China. Dalian Medical University, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China. Dalian Medical University, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China. Dalian Medical University, China, Sun Yat-sen University, Department of Otolaryngology-Head and Neck Surgery, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China, the First Affiliated Hospital of Sun Yat-sen University, Department of Pathology, China, Guangdong Experimental High School, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|